当前位置: X-MOL 学术Int. J. Radiat. Oncol. Biol. Phys. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Five-Year Results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial.
International Journal of Radiation Oncology • Biology • Physics ( IF 6.4 ) Pub Date : 2020-01-25 , DOI: 10.1016/j.ijrobp.2019.12.037
Sophie C J Bosma 1 , Femke Leij 1 , Sandra Vreeswijk 1 , Michiel de Maaker 2 , Jelle Wesseling 2 , Marc van de Vijver 3 , Astrid Scholten 1 , Sofia Rivera 4 , Celine Bourgier 5 , Guillaume Auzac 4 , Theodoros Foukakis 6 , Tobias Lekberg 6 , Desiree Bongard 7 , Claudette Loo 8 , Emiel Rutgers 9 , Harry Bartelink 1 , Paula H M Elkhuizen 1
Affiliation  

Purpose

In this multicenter phase 2 feasibility study, we investigated the impact of preoperative accelerated partial breast irradiation (PAPBI) on local control, breast fibrosis, and cosmetic outcome.

Methods and Materials

Women aged >60 years with an invasive, unifocal (mammography and magnetic resonance imaging), nonlobular adenocarcinoma of the breast were treated with PAPBI. Six weeks after radiation therapy, a wide local excision was performed. Radiation therapy consisted of 10 × 4 Gy (2010-2013) or 5 × 6 Gy (after 2013) to the tumor (gross target volume) with a 25 mm margin (20 mm from gross target volume to clinical target volume, 5 mm planning target volume).

Results

One hundred thirty-three patients treated between 2010 and 2016 were analyzed with a median follow-up of 5.0 years (0.9-8.8 years). Seventy-eight (59%) patients were treated with 10 × 4 Gy in 2 weeks and 55 (41%) patients with 5 × 6 Gy in 1 week. Eighteen postoperative complications (14%) occurred in 15 patients (11%). The proportion of patients with no to mild fibrosis in the treated part of the breast at 2 years and later time points was around 90%. Cosmesis improved over time in several patients: excellent to good cosmetic score as rated by the physician was 68% at 6 months and 92% at 5 years. Seventy-seven percent (6 months) to 82% (5 years) of patients were “satisfied” or “very satisfied” with their cosmetic outcome. Three recurrences were detected in the biopsy track and 1 recurrence in the ipsilateral breast.

Conclusions

PAPBI is a feasible method with a low postoperative complication rate, limited fibrosis, and good to excellent cosmetic outcome. The local recurrence rate was 3% at 5 years; however, no local recurrences were observed since removal of the needle biopsy track.



中文翻译:

术前加速部分乳房照射(PAPBI)试验的五年结果。

目的

在这项多中心2期可行性研究中,我们调查了术前加速局部乳房照射(PAPBI)对局部控制,乳房纤维化和美容结局的影响。

方法与材料

年龄大于60岁且有创,单灶(乳房X线照相和磁共振成像),乳腺非小叶腺癌的女性接受PAPBI治疗。放射治疗后六周,进行了广泛的局部切除。放射疗法由10×4 Gy(2010-2013)或5×6 Gy(2013年之后)组成,对肿瘤(总目标体积)的放射治疗具有25 mm的余量(从总目标体积到临床目标体积为20 mm,规划为5 mm)目标数量)。

结果

对2010年至2016年接受治疗的133例患者进行了分析,中位随访时间为5.0年(0.9-8.8年)。七十八(59%)的患者在2周内接受了10×4 Gy的治疗,55(41%)的患者在1周内接受了5×6 Gy的治疗。15例患者(11%)发生了18例术后并发症(14%)。在2年及以后的时间点,乳房的受治疗部位中无轻度纤维化的患者比例约为90%。随着时间的推移,一些患者的美容效果得到了改善:如医生所评价的那样,优秀至良好的美容评分在6个月时为68%,在5年时为92%。77%(6个月)至82%(5年)的患者对其美容效果“满意”或“非常满意”。在活检中发现3例复发,在同侧乳房中1例复发。

结论

PAPBI是一种可行的方法,具有较低的术后并发症发生率,有限的纤维化和良好的美容效果。5年局部复发率为3%;然而,由于去除了活检针,因此未观察到局部复发。

更新日期:2020-03-27
down
wechat
bug